PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation. - Wikidata - wikimedia - TriplyDB

PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.

PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.

http://www.wikidata.org/entity/Q37166823

about

Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease Disorders of the calcium-sensing receptor and partner proteins: insights into the molecular basis of calcium homeostasis A physiologic-based approach to the evaluation of a patient with hyperphosphatemia Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia Use of parathyroid hormone in hypoparathyroidism.Iatrogenic nephrocalcinosis with acute renal failure: an underestimated complication after parathyroidectomy?Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure PTH(1-84) Administration in Hypoparathyroidism Transiently Reduces Bone Matrix Mineralization.Excessive signal transduction of gain-of-function variants of the calcium-sensing receptor (CaSR) are associated with increased ER to cytosol calcium gradient.The role of the calcium-sensing receptor in bone biology and pathophysiology Review of Hypoparathyroidism.Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones.Impact of recombinant PTH on management of hypoparathyroidism: a systematic review.The calcium-sensing receptor in bone--mechanistic and therapeutic insights.The calcium-sensing receptor in bone metabolism: from bench to bedside and back.Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH).Repurposing a novel parathyroid hormone (PTH) analog to treat hypoparathyroidism.Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcaemia - a German survey.Calcimimetic and calcilytic therapies for inherited disorders of the calcium-sensing receptor signalling pathway.Increased trabecular volumetric bone mass density in Familial Hypocalciuric Hypercalcemia (FHH) type 1: a cross-sectional study.Identification and characterization of D410E, a novel mutation in the loop 3 domain of CASR, in autosomal dominant hypocalcemia and a therapeutic approach using a novel calcilytic, AXT914.

P2860

Q24629572-E2C8AFEA-3341-40B7-A9BD-C13EFA67390E Q26863412-A8B6A7F4-09DA-4A65-8B19-4975ADE27D57 Q28078843-A8BA6065-5CF3-446D-A69A-3A202B15DFEA Q33894092-7B5155AF-DC71-4555-BB6D-C292B02F4801 Q34453896-05B38701-F7FC-4BC5-89C8-E1C7B129AA15 Q35043115-82C2B6A7-0560-4EA4-BDAE-73F8DFBA6B00 Q35574079-15BF6DFF-3DAB-44AE-9AB5-B640B4C1603C Q36103534-D6287EC8-0DE4-4DEC-BFC9-DA5270798F4D Q36795949-3BC8FA0D-C216-47D7-AB65-C14A5E61278D Q37309059-D8A9D5F7-2740-4D3E-BEEE-5A54120CC82B Q37438290-54ABEAC3-835B-43FB-A307-4E9CF9A9BB79 Q37587224-B1C8B9FF-1C3C-494B-8AC3-E88479E8B192 Q38257346-EFD1E48E-1E0C-4911-9CF5-7A6F8104A8CA Q38310672-BBF6CAAF-6E46-494A-B34F-E07EB50CD5FE Q38370639-808984BC-F776-4C51-9874-0563A7B57ED2 Q38534776-2D228716-BA7B-49A2-8BC1-145CE5C8B01A Q40946883-24A977C2-80EC-417C-A6EA-C8691A424CBC Q42689961-8297D7A3-9011-4B63-B9D4-E305C31765D2 Q44723293-8A59EBFB-6066-453A-8CA2-2ED551A9FD92 Q47414200-93D63467-67A0-42F6-B9AB-2311BBACEB85 Q53063892-3679A5BF-DD84-434D-B581-901FEB70EAAB Q53359387-E30B5BE2-DA0D-4B56-992B-FF5AA0905962

P2860

PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.

http://www.wikidata.org/entity/Q37166823

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

PTH(1-34) replacement therapy ...... dic calcium receptor mutation.

@en

type

label

PTH(1-34) replacement therapy ...... dic calcium receptor mutation.

@en

prefLabel

PTH(1-34) replacement therapy ...... dic calcium receptor mutation.

@en

P1433

Q37166823-1EE682BA-F480-450C-A94D-0D9DFA199003

P1476

Q37166823-FAD84C1D-D037-4BAB-A01F-A6F569823046

P2093

Q37166823-2531CC61-7655-4D85-809A-CFAB37CAB42F

Q37166823-435EA736-6A18-4556-9601-27D544DF7A78

Q37166823-8C582A86-FE3A-49B6-B0FD-F84430A40CFC

Q37166823-99EF4F9C-2E92-4D76-BA7A-C2BE1333702B

Q37166823-A99BD048-1982-4EB1-B2EC-488DCFB21F9B

Q37166823-AA8F5B4F-C568-4C39-AB85-A253F96C1054

Q37166823-BF513201-0FB2-4DB4-98AB-E18838E5A44A

Q37166823-C986303A-5221-409E-B54B-CA497973E175

Q37166823-F12BB687-98C8-422F-9408-3F316A397B5A

P2860

Q37166823-01B6B5A7-F981-4221-AC5E-A37E6E49CF7B

Q37166823-0D0BA2C0-CC7A-4E71-8B9B-CF08A531E068

Q37166823-1EDEED25-8687-466F-AD6B-566A3DC3FCA3

Q37166823-20D48129-B124-4884-8CF7-F6BCFD03DEF3

Q37166823-2A5FF5CA-34EF-42BC-8AC7-7BEC4AF6B17B

Q37166823-2F0F82D8-6489-499E-97A5-048FF247CA79

Q37166823-3A590540-C77F-4A3B-9043-AEAB4AC60E42

Q37166823-3D2E775E-ED00-4D94-94CB-E8E2A6656369

Q37166823-4E9BC6BF-483E-44E9-8BC4-FEF4DD8F53F5

Q37166823-69CFAB44-1293-4031-AD16-C7B62C45B90F

P304

Q37166823-5C04E546-C9F2-4F10-A584-FAD5633B51A8

P31

Q37166823-57C7490E-A589-4C49-BCC4-46667E79E289

P356

Q37166823-9990C033-7B1B-42A1-AC7A-72A0A5AF2A98

P433

Q37166823-EF376CDF-81F3-4824-8F32-C17EC5029E51

P478

Q37166823-AFA72276-3FF7-472C-9CFD-2A622D080206

P577

Q37166823-257B24C8-97CA-4C14-9FD5-68AF46B56B12

P5875

Q37166823-1049634A-023B-4158-961F-655F9957E3FF

P698

Q37166823-C01CF83A-5D77-4206-A3DB-2BC780A3FA56

P932

Q37166823-B6C9EDE0-D70E-4ACA-B486-C2E7649973CB

P356

P1433

Journal of Bone and Mineral Research

P1476

PTH(1-34) replacement therapy ...... dic calcium receptor mutation.

@en

P2093

David W Dempster

http://www.w3.org/2001/XMLSchema#string

Hua Zhou

http://www.w3.org/2001/XMLSchema#string

Jaime S Brahim

http://www.w3.org/2001/XMLSchema#string

James C Reynolds

http://www.w3.org/2001/XMLSchema#string

Karen K Winer

http://www.w3.org/2001/XMLSchema#string

Klaus Klaushofer

http://www.w3.org/2001/XMLSchema#string

Michael T Collins

http://www.w3.org/2001/XMLSchema#string

Paul Roschger

http://www.w3.org/2001/XMLSchema#string

Todd A Theman

http://www.w3.org/2001/XMLSchema#string

P2860

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

Normative data for iliac bone histomorphometry in growing children.

The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race.

Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism.

A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor.

Commentary on clinical safety of recombinant human parathyroid hormone 1-34 in the treatment of osteoporosis in men and postmenopausal women.

Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.

Bone mineralization density distribution in health and disease.

Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones.

P304

964-973

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1359/JBMR.081233

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23639112

http://www.w3.org/2001/XMLSchema#string

P698

19063686

http://www.w3.org/2001/XMLSchema#string

P932

2672210

http://www.w3.org/2001/XMLSchema#string